Stay updated on Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial

Sign up to get notified when there's something new on the Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The revision label in the page footer updates from v3.6.2 to v3.6.3. This reflects a minor site update without altering study data or page functionality.
    Difference
    0.0%
    Check dated 2026-07-03T23:58:24.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.2, replacing the previous v3.6.0, indicating a small site update; the study history information remains unchanged.
    Difference
    0.0%
    Check dated 2026-06-27T01:20:58.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Version history shows a new revision v3.6.0 replacing v3.5.5. A note has been added stating the study is no longer looking for participants.
    Difference
    0.2%
    Check dated 2026-06-12T14:50:30.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The footer now shows Revision: v3.5.5, replacing Revision: v3.5.4, indicating a new site release.
    Difference
    0.0%
    Check dated 2026-06-05T09:53:06.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The record history now shows Revision: v3.5.4 added, replacing the previous v3.5.3 to reflect a new release tag.
    Difference
    0.0%
    Check dated 2026-05-15T03:04:59.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The page’s display revision was updated from v3.5.2 to v3.5.3, reflecting a site/version update rather than any modification to the clinical trial record itself.
    Difference
    0.0%
    Check dated 2026-04-23T21:57:05.000Z thumbnail image

Stay in the know with updates to Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial page.